This invention belongs to the field of
plant molecular biology and
plant genetic engineering. Specifically, it discloses the application of the Nta11g04230
gene as a negative immune
regulator gene in tobacco (
Nicotiana tabacum L.) to improve tobacco
disease resistance. Silencing the Nta11g04230
gene in tobacco significantly enhances tobacco
immunity and increases resistance to
Phytophthora nicotineis, making it an ideal
susceptibility gene for improving tobacco resistance. Experimental
verification shows that silencing the Nta11g04230 gene increases tobacco
disease resistance, produces more
salicylic acid (SA), and upregulates the expression of the SA signaling pathway
marker gene NtPR1; while overexpressing the Nta11g04230 gene makes tobacco more susceptible to
disease, produces less SA compared to the
wild type, and downregulates the expression of the SA signaling pathway
marker gene NtPR1. This invention provides a new
target gene for improving tobacco disease resistance breeding. Using gene editing technologies such as
CRISPR-Cas9 or through transgenic methods to reduce the expression of this gene can enhance tobacco disease resistance, and thus be applied to tobacco disease resistance improvement.